A >1M€ SEED fundraising to get closer to the First in Human study

We are very pleased to welcome BEANGELS and NOSHAQ on board. Together with our historical investors, they put a >1M€ investment in Op2Lysis to ensure the scale-up and the industrial development of the production processes of O2L-001 to reach the regulatory studies and to get closer to the initiation of the clinical trial.

For more information about this SEED funding, read the Press Release: